Cyrus looks like a great hire and his resume couldn't be much more diametrically opposed from Nader's.

Snagging a CEO with experience in big pharma strategic development and capital markets with an MBA and a PhD in neuroscience seems like a fantasy after so many years of an amateur CEO learning as he went. Definitely seems like just about as good of a hire as could have been expected.